SB
TEVA icon

Simmons Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Simmons Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-26,445
Closed -$465K – 314
2017
Q3 		$465K Sell
26,445
-6,256
-19% -$141K 0.05% 238
2017
Q2 		$1.09M Sell
32,701
-50
-0.2% -$1.55K 0.12% 146
2017
Q1 		$1.05M Sell
32,751
-2,072
-6% -$70.7K 0.12% 140
2016
Q4 		$1.26M Sell
34,823
-2,105
-6% -$84K 0.14% 135
2016
Q3 		$1.7M Sell
36,928
-2,272
-6% -$119K 0.19% 109
2016
Q2 		$1.97M Sell
39,200
-2,100
-5% -$112K 0.22% 94
2016
Q1 		$2.21M Buy
+41,300
New +$2.42M 0.25% 84

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Simmons Bank's TEVA Position: Q4 2017 in Review

Simmons Bank sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 26,445 shares — an estimated $465K sold.

Simmons Bank first reported a position in TEVA in Q1 2016 and held it in 7 quarters. The position peaked at $2.21M in Q1 2016. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Simmons Bank reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Simmons Bank sold 26,445 Teva Pharmaceuticals shares in Q4 2017, an estimated $465K.
  • Simmons Bank first reported a position in Teva Pharmaceuticals in Q1 2016 and held it in 7 quarters.
  • Simmons Bank's Teva Pharmaceuticals position peaked at $2.21M in Q1 2016.
  • 507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Simmons Bank's 13F filing for Q4 2017, filed 13 Feb 2018.